Published June 7, 2024 | Version v1
Journal article Open

A Prospective Observational Study On Prescribing Patterns Of Drugs Used In Chronic Kidney Disease Management At Secondary Care Hospital

Description

ABSTRACT

One significant systemic ailment is chronic renal disease. Co-morbid illnesses combined with declining renal function cause patients to take more than one medication. Choosing the right medications is essential to preventing side effects. This study has a prospective observational design in which all patients with chronic kidney disease (CKD) are included in the analysis. Relevant data was acquired through the use of patient data collection forms, which were filled out and examined. In this study, 120 patients who had prescriptions for medications were reviewed prospectively; of these, 76 (63.33%) were men and 44 (36.66%) were women. According to demographic data, men are more likely to develop CKD. According to demographic information, patients between the ages of 41 and 60 were found to be high in 62 middle-aged individuals (51.66%) and low in young adults (7.83%) in the 19–30 age group. Anti-hypertensive medications were the most commonly prescribed class of pharmaceuticals, followed by cardiovascular, hematinic, and anti-diabetic medications. A total of 1.16% of prescriptions were written under their generic names. 10.96% of prescriptions included an injectable products. Antibiotic prescriptions made up 54.16% of all prescriptions. Ninety-three percent of the medications prescribed came from the WHO Essential medicines list. The study shows that the prescription of brand-name medications was frequently noticed using WHO core indicators, which were used to monitor the drug prescribing trend. This study concludes that CKD patients were more likely to be treated with diuretics, antihypertensives, oral hypoglycemic medications, and hematinic agents.

Keywords: CKD, prescribing patterns, antihyperetensives, hypoglycemic, prevalence, Polypharmacy.

Files

AJPTR143004.pdf

Files (503.3 kB)

Name Size Download all
md5:1976bcdd3905cc7270a75697764cf6c2
503.3 kB Preview Download

Additional details

Identifiers

EISSN
2249-3387

Related works

Is published in
2249-3387 (EISSN)

Dates

Available
2024-06-07

References

  • American Journal of PharmTech Research